Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:14 pm Sale | 13G | RAIN ONCOLOGY INC. RAIN | PERCEPTIVE ADVISORS LLC | 0 0% | -2,483,619 (Position Closed) | View |
| 2024-02-14 4:19 pm Sale | 13G | RAIN ONCOLOGY INC. RAIN | Samsara BioCapital L.P. | 0 0% | -2,260,652 (Position Closed) | View |
| 2024-02-07 07:45 am Sale | 13G | RAIN ONCOLOGY INC. RAIN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,523,282 (Position Closed) | View |
| 2024-02-02 4:00 pm Sale | 13D | RAIN ONCOLOGY INC. RAIN | TANG CAPITAL PARTNERS LP | 0 0% | -4,024,486 (Position Closed) | View |
| 2024-01-29 5:13 pm Sale | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -3,526,729 (Position Closed) | View |
| 2023-12-19 9:29 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | Vellanki Avanish | 2,550,910 7% | 171,617 (+7.21%) | View |
| 2023-12-18 4:35 pm Unchanged | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.8% | 0 (Unchanged) | View |
| 2023-12-18 4:03 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | Boxer Capital LLC | 2,933,152 9.9% | 117,590 (+4.18%) | View |
| 2023-11-24 11:33 am Purchase | 13G | RAIN ONCOLOGY INC. RAIN | BML Investment Partners L.P. | 1,815,953 6.6% | 1,815,953 (New Position) | View |
| 2023-10-13 4:53 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | TANG CAPITAL PARTNERS LP | 4,024,486 14.6% | 284,145 (+7.60%) | View |
| 2023-08-17 4:52 pm Unchanged | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.8% | 0 (Unchanged) | View |
| 2023-06-01 4:50 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | TANG CAPITAL PARTNERS LP | 3,740,341 14.1% | 3,740,341 (New Position) | View |
| 2023-05-24 5:31 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | Boxer Capital LLC | 2,815,562 9.9% | 305,435 (+12.17%) | View |
| 2023-05-10 12:51 pm Sale | 13G | RAIN ONCOLOGY INC. RAIN | Flynn James E | 0 0% | -2,796,261 (Position Closed) | View |
| 2023-02-14 5:00 pm Purchase | 13G | RAIN ONCOLOGY INC. RAIN | Samsara BioCapital L.P. | 2,260,652 9.1% | 2,260,652 (New Position) | View |
| 2023-02-14 3:01 pm Purchase | 13G | RAIN ONCOLOGY INC. RAIN | Cormorant Global Healthcare Master Fund LP | 2,733,977 9.99% | 796,176 (+41.09%) | View |
| 2023-02-14 2:39 pm Unchanged | 13G | RAIN ONCOLOGY INC. RAIN | PERCEPTIVE ADVISORS LLC | 2,483,619 9.3% | 0 (Unchanged) | View |
| 2023-01-30 4:35 pm Purchase | 13G | RAIN ONCOLOGY INC. RAIN | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,523,282 8.09% | 1,523,282 (New Position) | View |
| 2022-11-18 4:14 pm Purchase | 13G | RAIN ONCOLOGY INC. RAIN | Flynn James E | 2,796,261 9.99% | 2,796,261 (New Position) | View |
| 2022-11-10 4:51 pm Unchanged | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 14.2% | 0 (Unchanged) | View |